Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1991
06/21/1991WO1991008767A1 STABILIZATION OF GLYCOSYLIZED t-PA
06/21/1991WO1991008766A1 STABILIZATION OF t-PA pro
06/21/1991WO1991008764A1 SOLUBILIZATION OF t-PA
06/21/1991WO1991008763A1 Stabilization of k1k2p pro
06/21/1991WO1991008757A1 Method of treating ocular diseases by periocular administration of cyclosporine a or g
06/21/1991CA2071900A1 Method of treating ocular diseases by periocular administration of cyclosporine a or g
06/21/1991CA2046876A1 Stabilisation of glycosated t-pa
06/21/1991CA2032735A1 Substituted amino-acid derivatives; process for preparing the same and pharmaceutical compositions containing them
06/20/1991WO1991009126A1 Production of human basic fgf mutein
06/20/1991DE4039569A1 New inhibitors of retroviral protease(s) - useful especially to treat symptoms of AIDS
06/20/1991CA2070989A1 Production of human basic fgf mutein
06/20/1991CA2032675A1 Platelet-derived growth factor b chain analogs and method for homogeneous production thereof
06/19/1991WO1991008769A1 Pharmaceutical composition for treating or preventing retroviral infections
06/19/1991WO1991008752A1 Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor
06/19/1991EP0433225A1 Process for the production of biologically active protein (e.g. TGF)
06/19/1991EP0433140A1 New anti-allergic sustained-release pharmaceutical preparation
06/19/1991EP0433113A1 Stabilization and maintenance of the nerve growth factor biological activity by use of natural gangliosides or derivatives thereof
06/19/1991EP0433074A1 Method for treating cardiac malfunction
06/19/1991EP0432974A1 Cyclic renin inhibitors
06/19/1991EP0432695A2 Amino acid derivatives
06/19/1991EP0432510A1 Process for the preparation of genetic vectors for the nerve growth factor expression in eukaryotic cells
06/19/1991EP0432490A2 Immunostimulant agent
06/19/1991EP0432479A1 Anhydrous pharmaceutical formulations and dosage forms for the rectal administration of calcitonin
06/19/1991EP0432431A1 Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient
06/19/1991EP0432400A2 Pharmacologically active substance BPC, the process for its preparation and its use in the therapy
06/19/1991EP0432254A1 NUCLEIC ACID CODING FOR THE HUMAN TESTICULAR ANGIOTENSIN CONVERSION ENZYME (ECA) AND ITS APPLICATIONS, IN PARTICULAR FOR THE $i(IN VITRO) DETECTION OF SAID ENZYME IN THE ORGANISM
06/19/1991EP0432203A1 Legionellosis vaccines and methods for their production
06/19/1991EP0248047B1 Medicament with anti-tumoral action containing hexadecylphosphocholine
06/19/1991EP0203967B1 Onco-fetal specific monoclonal antibodies, methods of preparation and use
06/19/1991EP0201540B1 Envelope antigens of lymphadenopathy associated virus and their applications
06/19/1991CA2071972A1 Pharmaceutical compositions for treating or preventing retroviral infections
06/19/1991CA2032427A1 Benzodiazepines analogs
06/19/1991CA2032226A1 Benzodiazepine analogs
06/19/1991CA2032222A1 Benzodiazepine analogs doe treating panic syndrome and for directly inducing analgesia
06/18/1991US5025032 For ischemia or inflammation of brain or nervous system
06/18/1991US5025029 Method for augmenting fetal hemoglobin
06/18/1991US5024995 Phospholipids and proteins; free of carbohydrates, cholesterol and triglycerides
06/18/1991US5024841 Collagen wound healing matrices and process for their production
06/18/1991US5024838 Compositions for the treatment of skin injuries
06/18/1991US5024835 Conjugates of a vinca derivative carrying a detergent chain in the C-3 position
06/18/1991US5024833 Combined interferon/antiestrogen therapy for treatment of breast cancer
06/18/1991CA1285099C2 Methods and compositions for preparation of h-arg-x-z-y-tyr-r
06/18/1991CA1284961C Methods for purification of single-chain and double- chain tissue plasminogen activator
06/16/1991WO1991008774A1 Cytokine antibody for the treatment of sepsis
06/16/1991CA2071872A1 Cytokine antibody for the treatment of sepsis
06/16/1991CA2032430A1 Production of biologically active platelet-derived growth factor from high expression host cell systems
06/15/1991WO1991008755A1 Polypeptide with type iv collagen cell adhesion, spreading and motility activity
06/15/1991CA2071512A1 Polypeptide with type iv collagen cell adhesion, spreading and motility activity
06/15/1991CA2031394A1 Semisynthetic derivatives with immunomodulation activity, suitable for parenteral and oral administration
06/15/1991CA2017389A1 Alteration of ability of soluble cd4 protein to bind class ii mhc antigens
06/14/1991CA2032079A1 Method for treating cardiac malfunction
06/13/1991WO1991008483A1 Endothelial-derived il-8
06/13/1991WO1991008310A1 Detection of human adenovirus
06/13/1991WO1991008306A1 Polymorphism of human platelet membrane glycoprotein iib and diagnostic and therapeutic applications thereof
06/13/1991WO1991008305A1 Dna fragments and dna probes and primers based thereon
06/13/1991WO1991008298A2 Fusion proteins consisting of a ligand binding protein and a stable plasma protein
06/13/1991WO1991008297A1 Methods and materials for expression of human plasminogen variant
06/13/1991WO1991008291A2 Latency associated peptide and uses therefor
06/13/1991WO1991008290A1 RECOMBINANT GENE ENCODING HUMAN MACROPHAGE CARBOHYDRATE AND IgE-BINDING PROTEIN
06/13/1991WO1991008232A1 Cloning and expression of the blood-brain-barrier-specific protein ht7
06/13/1991WO1991008231A1 [Ala IL-8]77 AS A LEUKOCYTE ADHESION INHIBITOR
06/13/1991WO1991008229A1 Hirudine polyalkylene glycol conjugates
06/13/1991WO1991008228A1 Leucocyte elastasis and cathepsin g-blocking peptide
06/13/1991WO1991008225A1 Hexapeptides with sulphate ester groups
06/13/1991WO1991008223A1 Novel peptides derived from neuropeptide y
06/13/1991WO1991008221A1 Peptide inhibitors of hiv protease
06/13/1991WO1991008217A1 Human intestinal mucins
06/13/1991WO1991008214A1 Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor
06/13/1991WO1991008199A1 Amino acid derivative
06/13/1991WO1991007997A1 An aerosol preparation of glutathione and a method for augmenting glutathione level in lungs
06/13/1991WO1991007993A1 Anti-inflammatory and anti-adhesive factors
06/13/1991WO1991007992A1 Proliferative action of leukaemia inhibitory factor on satellite cells
06/13/1991WO1991007988A1 Megakaryocyte production
06/13/1991WO1991007983A1 Protection of intraocular structures
06/13/1991WO1991007982A1 Treatment of hsv
06/13/1991WO1991007981A1 Treatment for damaged nerve tissue
06/13/1991WO1991007967A2 Method of preventing or limiting reperfusion damage
06/13/1991WO1991007951A1 Homologous guluronic acid alginate coating composition for in-vivo application and implantation and method of using same
06/13/1991WO1991007948A1 Pancreatin preparations
06/13/1991WO1991006293A3 Composition containing 2,3-butanedione monoxime and method for reversibly arresting muscle activity
06/13/1991WO1991002062A3 C-erbb-2 external domain: gp75
06/13/1991DE3941009A1 Eliminierung von aktivierten lymphozyten Elimination of activated lymphocytes
06/13/1991CA2069440A1 An aerosol preparation of glutathione and a method for augmenting glutathione level in lungs
06/13/1991CA2045630A1 Proliferative action of leukaemia inhibitory factor on satellite cells
06/12/1991WO1991008679A1 Functional food
06/12/1991EP0432134A1 Hybridoma cell lines and monoclonal antibodies
06/12/1991EP0432117A1 Composition for treatment of inflammation
06/12/1991EP0431972A2 Macrocyclic lactones having renin inhibiting properties
06/12/1991EP0431933A1 Formulated medicines for enhancing the efficacy of betalactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria
06/12/1991EP0431811A1 Thrombolytic agents
06/12/1991EP0431784A2 Methods for treating retroviral infection
06/12/1991EP0431668A1 Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
06/12/1991EP0431541A2 Toxoplasma gondii antigen, its production and use
06/12/1991EP0431350A1 New polypeptide compound and a process for preparation thereof
06/12/1991EP0431327A1 Synthetic vaccine for the specific induction of cytotoxic T-lymphocytes
06/12/1991EP0431323A1 Antitumor antibiotic BU-3983T
06/12/1991EP0431277A1 Combination of a thromboxane A2 antagonist with a thrombolytic agent
06/12/1991EP0431135A1 Particle-mediated transformation of animal somatic cells
06/12/1991EP0431128A1 Self-assembled, defective, non-self-propagating viral particles
06/12/1991EP0431113A1 Atrial peptide derivatives
1 ... 3006 3007 3008 3009 3010 3011 3012 3013 3014 3015 3016 3017 3018 3019 3020 3021 3022 3023 3024 3025 3026 ... 3163